BLAVIALPriority Review
Approved
Feb 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15
Clinical Trials (5)
Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation
Started Nov 2010
2 enrolled
Multiple Myeloma
Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma
Started Jun 2010
75 enrolled
Stage IIIC MelanomaStage IV Melanoma
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
Started Oct 2008
7 enrolled
Metastatic Pancreatic Cancer
Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
Started Jul 2008
21 enrolled
Peripheral T-Cell Lymphoma
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
Started Apr 2008
24 enrolled
Lymphoma